Central serous chorioretinopathy in younger and older adults.
about
Characteristics of intraretinal deposits in acute central serous chorioretinopathyClinical applications of optical coherence tomography in the posterior pole: the 2011 José Manuel Espino Lecture - Part IIAdvances in the treatment of central serous chorioretinopathyACUTE CENTRAL SEROUS CHORIORETINOPATHY: Factors Influencing Episode DurationChoroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level.Serum cortisol and testosterone levels in idiopathic central serous chorioretinopathy.Polypoidal choroidal vasculopathy and history of central serous chorioretinopathy.Long-term results of half-dose photodynamic therapy for chronic central serous chorioretinopathy with contrast sensitivity changes.Helicobacter pylori as a potential target for the treatment of central serous chorioretinopathyCadherin 5 is regulated by corticosteroids and associated with central serous chorioretinopathyMorphologic changes in acute central serous chorioretinopathy using spectral domain optical coherence tomography.Central serous chorioretinopathy: update on pathophysiology and treatment.Factors influencing the visual acuity of chronic central serous chorioretinopathyEpidemiology of idiopathic central serous chorioretinopathy in Taiwan, 2001-2006: a population-based study.Finasteride for chronic central serous chorioretinopathy.Acute visual loss induced by dexamethasone during neoadjuvant docetaxol.Choroidal thickness in both eyes of patients with unilaterally active central serous chorioretinopathy.Clinical characteristics of polypoidal choroidal vasculopathy associated with chronic central serous chorioretionopathyComparing half-dose photodynamic therapy with high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy (the PLACE trial): study protocol for a randomized controlled trial.Changes in Choroidal Structures in Eyes with Chronic Central Serous Chorioretinopathy after Half-Dose Photodynamic TherapyComparison of Serum Cortisol and Testosterone Levels in Acute and Chronic Central Serous ChorioretinopathyLong-Term Outcome of Half-Dose Verteporfin Photodynamic Therapy for the Treatment of Central Serous Chorioretinopathy (An American Ophthalmological Society Thesis).SPIRONOLACTONE FOR NONRESOLVING CENTRAL SEROUS CHORIORETINOPATHY: A RANDOMIZED CONTROLLED CROSSOVER STUDY.Association of Choroidal Neovascularization and Central Serous Chorioretinopathy With Optical Coherence Tomography Angiography.Bilateral simultaneous central serous chorioretinopathy in a teenage girl with systemic arterial hypertension.Oral Mineralocorticoid-Receptor Antagonists: Real-Life Experience in Clinical Subtypes of Nonresolving Central Serous Chorioretinopathy With Chronic Epitheliopathy.Efficacy of half-fluence photodynamic therapy depending on the degree of choroidal hyperpermeability in chronic central serous chorioretinopathy.Angiographic characteristics of central serous chorioretinopathy in an Egyptian population.Optical coherence tomographic angiography of choroidal neovascularization associated with central serous chorioretinopathy.Seven-year evaluation of idiopathic multiple retinal pigment epithelium detachmentsSubfoveal choroidal thickness after photodynamic therapy in patients with acute idiopathic central serous chorioretinopathySubfoveal Choroidal Thickness in Central Serous Chorioretinopathy: A Meta-Analysis.En face enhanced-depth swept-source optical coherence tomography features of chronic central serous chorioretinopathyEffects of photodynamic therapy with verteporfin for the treatment of chronic central serous chorioretinopathy: An uncontrolled, open-label, observational studyIsolated multiple pigment epithelial detachments with unknown cause.Axial length in unilateral idiopathic central serous chorioretinopathy.Diagnosed a Patient with Central Serous Chorioretinopathy? Now What?: Management of Central Serous Chorioretinopathy.Alcoholic liver disease and bilateral multifocal central serous retinopathy: a case reportVisual and Anatomical Outcomes of Spironolactone Therapy in Patients with Chronic Central Serous Chorioretinopathy.Fundus autofluorescence imaging patterns in central serous chorioretinopathy according to chronicity.
P2860
Q26830639-CA049409-6B64-4586-9F47-AFCC3EDB057DQ26864721-FDD12A77-0DBD-4F7A-8618-97C17C28FDA8Q28088443-9575A8DF-79C0-4FBB-894C-0250DE9A09B4Q30490648-09F4C1C9-9B50-4DE9-9EEE-C21A9EFE92E5Q33195722-13DCBD7E-D56C-4B83-BB3C-8433897A5773Q33616095-64C1B6DB-4B7B-4C84-B19F-06ACC93DE7CDQ34055052-0EBD1EE1-D7BB-40C4-93DD-F6318A1806D0Q34334673-18F4B025-7247-4DC0-AB56-1D67DCA38C1BQ34423329-537F518A-4577-4436-AB6C-A2346111F1A7Q34434358-D1386467-A36D-4156-B85D-E2BDDD7E7003Q34444223-C3DEB23A-94D4-4321-9CC0-5E0E33FFC5E7Q34587658-20CABF1E-F795-4C24-A219-BB9AA3DFDDA4Q34695063-183162B5-1C4D-43DC-A3A2-9E6C45FF0425Q34796150-9B3966A2-5593-41D1-A824-730D8F0789DCQ35050617-DC2AD580-5779-4EDB-96BB-23D415F50785Q35180971-26ECF6EA-139D-4D89-BBDF-940B1837255BQ35603572-BA866285-68D0-4196-A14A-BEA6C3EDE99BQ35707962-28007451-DCFA-4EC1-BF0D-6B7B3078ED05Q35782233-A6516A88-2BCD-42EA-AAF0-1667123BB9DAQ36135515-32E0CCE0-EC9B-4F3C-91E7-5084551D079AQ36342988-E8352AE4-285A-4709-9E83-BA8E9B5B6A63Q36407625-16A6AC7F-F101-4CB8-91EE-BBEF51F76F00Q36419719-F687F8D1-18A3-4A2E-866A-1A277D79D170Q36487164-6F1142C1-29BD-4D6A-9FBD-158716954E11Q36508224-6641EF87-19B9-4A8C-BEDA-D8955883A92AQ36663776-3045B008-E013-4947-8FCF-6071EF7EE32EQ36685488-A0398F80-9ECE-4A1B-A1AB-D862DB685A1AQ36955739-247046A0-0FD9-4955-B278-D70364924416Q37108628-A08D1FCA-A241-432C-B392-F263D048803EQ37350652-BB3A5009-390E-4AF6-A020-0417E82491A4Q37478532-B3402809-5CEA-49BA-A94B-4BDDEDD7AD31Q37580515-10788BB2-99BE-433C-9BBD-9E7EAB70F528Q37619588-CF15A715-5EF0-4191-9A9B-610C16BE5146Q37667426-DA52EE3F-4605-4758-80EC-D1910397381BQ37677808-D7E35B88-4524-40E2-8CD7-F33EF644CF5DQ38413640-93313CB1-B44E-4438-8398-73DC9B1D3DABQ38644045-45FCF830-34BE-48EB-AF1A-72D6DC398C69Q39294545-F5D1256C-C07C-4A9F-A6EB-AD972F7496C6Q41112838-349AC605-02A6-4069-B748-79A94241D096Q41641788-420C6912-36B9-458C-8FD3-A3F89681A1EB
P2860
Central serous chorioretinopathy in younger and older adults.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Central serous chorioretinopathy in younger and older adults.
@en
Central serous chorioretinopathy in younger and older adults.
@nl
type
label
Central serous chorioretinopathy in younger and older adults.
@en
Central serous chorioretinopathy in younger and older adults.
@nl
prefLabel
Central serous chorioretinopathy in younger and older adults.
@en
Central serous chorioretinopathy in younger and older adults.
@nl
P2093
P1433
P1476
Central serous chorioretinopathy in younger and older adults.
@en
P2093
Slakter JS
Sorenson JA
Yannuzzi LA
P304
2070-9; discussion 2079-80
P577
1996-12-01T00:00:00Z